A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant Effect of a Single Ketamine Infusion: A Randomized Clinical Trial

What is it about?

Intravenous ketamine has rapid-acting antidepressant properties, but these effects typically dissipate quickly in the absence of repeated infusions. Here we present novel evidence that a fully automated, computer-based approach can efficiently extend the duration of rapid clinical response among depressed patients following a single ketamine infusion.

Featured Image